ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 38 filers reported holding ADC THERAPEUTICS SA in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $24,304 | +557.6% | 14,641 | +255.4% | 0.00% | – |
| Q3 2023 | $3,696 | -70.0% | 4,120 | -28.0% | 0.00% | – |
| Q2 2023 | $12,300 | – | 5,721 | +8981.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 63 | -97.9% | 0.00% | – |
| Q4 2022 | $11 | -100.0% | 2,935 | -69.0% | 0.00% | -100.0% |
| Q3 2022 | $46,000 | +666.7% | 9,473 | +1253.3% | 0.00% | – |
| Q2 2022 | $6,000 | -40.0% | 700 | -5.0% | 0.00% | – |
| Q1 2022 | $10,000 | -77.3% | 737 | -66.3% | 0.00% | -100.0% |
| Q4 2021 | $44,000 | +4300.0% | 2,189 | +4764.4% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 45 | -45.1% | 0.00% | – |
| Q1 2021 | $2,000 | -98.6% | 82 | -98.2% | 0.00% | -100.0% |
| Q4 2020 | $147,000 | – | 4,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 11,167,800 | $24,010,770 | 3.60% |
| Sio Capital Management, LLC | 4,020,705 | $8,644,516 | 2.20% |
| Redmile Group, LLC | 14,049,935 | $30,207,360 | 1.16% |
| Vantage Consulting Group Inc | 885,520 | $1,903,868 | 1.10% |
| Blue Owl Capital Holdings LP | 733,568 | $1,577,171 | 0.97% |
| AlphaCentric Advisors LLC | 778,000 | $1,672,700 | 0.93% |
| Affinity Asset Advisors, LLC | 600,000 | $1,290,000 | 0.45% |
| GCM Grosvenor Holdings, LLC | 410,888 | $883,409 | 0.38% |
| Indie Asset Partners, LLC | 93,839 | $201,754 | 0.22% |
| Frazier Life Sciences Management, L.P. | 1,647,030 | $3,541,115 | 0.21% |